- Home
- AMOD vs CTXR Comparison
AMOD vs CTXR Comparison
Compare AMOD & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMOD
- CTXR
- Stock Information
- Founded
- AMOD 2014
- CTXR 2007
- Country
- AMOD United States
- CTXR United States
- Employees
- AMOD N/A
- CTXR N/A
- Industry
- AMOD
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- AMOD
- CTXR Health Care
- Exchange
- AMOD NYSE
- CTXR Nasdaq
- Market Cap
- AMOD 15.8M
- CTXR 14.6M
- IPO Year
- AMOD N/A
- CTXR N/A
- Fundamental
- Price
- AMOD $1.44
- CTXR $0.94
- Analyst Decision
- AMOD
- CTXR Strong Buy
- Analyst Count
- AMOD 0
- CTXR 2
- Target Price
- AMOD N/A
- CTXR $54.50
- AVG Volume (30 Days)
- AMOD 79.0K
- CTXR 142.3K
- Earning Date
- AMOD 05-27-2025
- CTXR 05-23-2025
- Dividend Yield
- AMOD N/A
- CTXR N/A
- EPS Growth
- AMOD N/A
- CTXR N/A
- EPS
- AMOD 0.13
- CTXR N/A
- Revenue
- AMOD N/A
- CTXR N/A
- Revenue This Year
- AMOD N/A
- CTXR N/A
- Revenue Next Year
- AMOD N/A
- CTXR N/A
- P/E Ratio
- AMOD $10.29
- CTXR N/A
- Revenue Growth
- AMOD N/A
- CTXR N/A
- 52 Week Low
- AMOD $1.02
- CTXR $0.68
- 52 Week High
- AMOD $13.49
- CTXR $26.25
- Technical
- Relative Strength Index (RSI)
- AMOD N/A
- CTXR 51.36
- Support Level
- AMOD N/A
- CTXR $0.65
- Resistance Level
- AMOD N/A
- CTXR $0.82
- Average True Range (ATR)
- AMOD 0.00
- CTXR 0.09
- MACD
- AMOD 0.00
- CTXR 0.04
- Stochastic Oscillator
- AMOD 0.00
- CTXR 85.69
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing, and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.